SMAD4 and breast carcinoma: To do this, we followed a complementary approach, where we selected a SMAD4-negative human breast cancer cell line [58], MDA MB 468, and aimed to determine the effect of BMP stimulation on β-CATENIN protein stability in the absence of endogenous SMAD4 expression.